title: Targeting LncRNAs in Cardiovascular Disease: Options and Expeditions.
authors.affiliation: From the Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Stefan
authors.initials: S
authors.lastname: Haemmig
authors.affiliation: From the Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. mfeinberg@partners.org.
authors.forename: Mark W
authors.initials: MW
authors.lastname: Feinberg
mesh_terms: D002318:Cardiovascular Diseases / Q000235:genetics / Q000628:therapy*; D018388:Codon, Terminator; D017353:Gene Deletion; D000072669:Gene Editing / Q000379:methods*; D055785:Gene Knockdown Techniques; D020868:Gene Silencing; D006801:Humans; D047468:Immunoprecipitation; D058990:Molecular Targeted Therapy / Q000379:methods*; D062085:RNA, Long Noncoding / Q000037:antagonists & inhibitors / Q000235:genetics*; D016601:RNA-Binding Proteins / Q000187:drug effects
chemical_list: D018388:Codon, Terminator; D062085:RNA, Long Noncoding; D016601:RNA-Binding Proteins
keywords: CRISPR; cardiovascular disease; gene editing; knockout; lncRNA